Skip to main content
. 2017 Nov 14;2017:7069242. doi: 10.1155/2017/7069242

Figure 1.

Figure 1

Anti-EBV reactivation antibodies in GC. EBV-positive GC samples were considered after a PCR analysis detecting EBV-positive ≥40,000 viral genomes. Comparisons were made between EBV-positive and EBV-negative GCs and controls. The EBV-positive group presented higher VCA-IgG titers compared with the EBV-negative and control groups (p = 0.035). The medians of the VCA-IgG titers were EBV-positive patients (122 HU/ml), EBV-negative (73.4 HU/ml), and HI controls (74.1 HU/ml).